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The role of nitric oxide (NO) in T cells remains con-
troversial, and the origin and localization of endoge-
nous NO and whether it regulates lymphocyte activa-
tion are unclear. We show here that, within minutes of
binding to antigen, T cells produce NO via endothelial
nitric oxide synthase (eNOS). This process required
increased intracellular Ca2+ and phosphoinositide3-
kinase activity. By using an eNOS-green fluorescent
fusion protein and fluorescent probes to detect NO,
we show that eNOS translocates with the Golgi appa-
ratus to the immune synapse of T helper cells en-
gaged with antigen-presenting cells (APC), where it
was fully activated. Overexpression of eNOS pre-
vented the central coalescence of CD3 at the T cell-
APC contact site, which was accompanied by in-
creased phosphorylation of CD3z chain, ZAP-70, and
extracellular signal-regulated kinases and increased
IFN-g synthesis, but reduced production of IL-2.
Therefore, eNOS-derived NO selectively potentiates
T cell receptor signaling to antigen at the immunolog-
ical synapse.
*Correspondence: jmserrador@cnic.es
6 These authors contributed equally to this work.Introduction
Nitric oxide (NO) is one of the most important signaling
molecules produced by macrophages and natural killer
(NK) cells during immune responses (Diefenbach et al.,
1998). NO is also produced by T lymphocytes in re-
sponse to chemokines and mitogens (Bogdan, 2001),
suggesting an important role in this cell type; however,
it has been unclear where in T cells NO synthesis takes
place and what its function is in T cell activation.
NO is synthesized by conversion of L-arginine to L-cit-
rulline by nitric oxide synthases (NOS), of which three ma-
jor isoenzymes are known: neuronal nNOS, inducible
iNOS, and endothelial eNOS (Knowles and Moncada,
1994; Alderton et al., 2001). The endogenous source of
NO during T cell activation has been unclear, but there
is indirect evidence to suggest action via eNOS. All NOS
isoenzymes require binding of Ca2+, but in endothelial
cells eNOS is also specifically activated in a Ca2+-depen-
dent manner by the phosphoinositide 3-kinase (PI3-K)-
Akt pathway through phosphorylation of Ser1179 (Fulton
et al., 1999). This activity is regulated by the subcellular
localization of eNOS to the Golgi apparatus or by its bind-
ing to caveolin in cholesterol-rich plasma membrane
caveolae (Fulton et al., 2004). In T lymphocytes, PI3-K
activity and the release of intracellular Ca2+ both occur
in response to T cell receptor (TCR) binding to antigen
on antigen-presenting cells (APC) (Kane and Weiss,
2003).
A key event in the antigen-specific interaction of
T cells with APC is the formation of the immunological
synapse, in which the TCR complex and the adhesion
receptor LFA-1 are organized in central and peripheral
supramolecular activation clusters (SMAC), respectively
(Monks et al., 1998). Antigen-dependent T cell activation
also involves translocation of the microtubule-organiz-
ing center (MTOC) and the associated Golgi apparatus
to the contact site with the APC (Kupfer et al., 1986).
The exact function of the immunological synapse re-
mains unknown, but it is thought to be associated with
sustained T cell activation, balancing positive and nega-
tive cell proliferation signals (Huppa et al., 2003; Lee
et al., 2003).
NO can affect T cell proliferation positively or nega-
tively, depending on the species, concentration, and
source (Bogdan, 2001). NO from iNOS-expressing mye-
loid cells suppresses mouse T cell proliferation (Mazzoni
et al., 2002), whereas both proliferative and antiprolifera-
tive effects of NO on human T cells have been identified
by L-arginine analogs and NO donors, respectively (Sris-
kandan et al., 1996; Fiorucci et al., 2004). These effects
may be regulated by NO-mediated activation of soluble
guanylate cyclase and the consequent production of
cGMP (Niedbala et al., 2002). However, cGMP-indepen-
dent mechanisms of NO action have recently been iden-
tified, and prominent among them are the regulation of
signaling cascades and transcription factors (Bogdan,
2001). These mechanisms may be implicated in T cell
responses: NO production by T cells costimulated with
antibodies to CD3 and CD28 increases Ca2+ signaling
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754(Nagy et al., 2003), and the activities of mitogen-activated
protein kinases (MAPK) are regulated by treatment with
pharmacological NO donors and NOS inhibitors (Lander
et al., 1996).
We have investigated the mechanism by which en-
dogenous NO regulates T cell activation. We show that
PI3-K-Akt activity and intracellular Ca2+ release were
both required for NO synthesis in response to TCR en-
gagement by superantigens or antigenic peptides on
APC. Moreover, in T cell-APC conjugates, eNOS trans-
located to the immunological synapse, where it was
activated. This localized eNOS activity disrupted the or-
ganization of CD3 at the central SMAC (cSMAC) and
enhanced the phosphorylation of TCR-associated prox-
imal elements, thereby increasing IFN-g synthesis but
reducing the production of IL-2.
Results
Antigen-Specific Production of NO in Human T Cells
To determine whether human T cells produce NO in re-
sponse to TCR engagement, we stimulated TCR-Vb8
J77 cells, highly purified T lymphoblasts, and peripheral
blood T lymphocytes (PBTs) with CD3 Abs. NO concen-
trations increased rapidly and progressively, reaching
approximately 40 nM after 40 min in J77 cells and 20
nM in PBTs and T lymphoblasts (Figure 1A). No signifi-
cant NO increases were detected in cells pretreated
with the generic NOS inhibitor N-nitro-L-arginine (NLA).
Synthesis of NO was similarly increased by exposure
of T cells to superantigens and antigenic peptides. In
these experiments, Raji APC were pulsed with Staphy-
lococcus enterotoxin superantigen E (SEE), and then in-
cubated with J77 cells. Alternatively, conjugates were
formed between hemaglutinin (HA)-specific TCR-trans-
fected CH7C17 cells and the HOM-2 APC. Synthesis of
NO by J77 and CH7C17 cells increased in the presence
of APC bearing SEE and HA peptides, respectively, and
this was inhibited by pretreating cells with NLA
(Figure 1B). Control experiments with paraformalde-
hyde-fixed Raji cells yielded similar results, discounting
the possible contribution of NO by APC (Figure 1B; Reil-
ing et al., 1996; Mannick et al., 1999).
In J77 cells preloaded with the NO-sensitive probe
DAF-FM diacetate (Kojima et al., 1999), fluorescence
analysis of T cell-APC conjugates indicated that this
production was mainly concentrated at the contact
site with the APC in 40% of SEE-specific cell conjugates,
reducing to 23% in the presence of NLA (Figures 1C
and 1D). Similar polarization was observed in peptide-
specific CH7C17-HOM-2 cell conjugates (Figure 1C).
Quantitative subcellular analysis of NO production in
SEE-specific T cell-APC conjugates showed that DAF
fluorescence was 2-fold higher at cell-cell contacts
than in the cytoplasm, and this ratio was reduced to
1.4 in the presence of NLA (Figure 1D).
To determine whether superantigens also stimulated
the release of NO from primary T cell-APC conjugates,
we incubated T lymphoblasts with either mature or im-
mature dendritic cells (DCs) in the presence of superan-
tigens (Figure 1E). NO increased in T lymphoblasts only
when these cells formed conjugates with superantigen-
pulsed mature DCs (Figures 1E and 1F).Taken together, these results indicate that during
antigen-specific cell-cell interactions, T lymphocytes
produce NO near the contact sites with APCs.
NOS Expression in T Cells
To investigate the enzymatic source of early NO gener-
ated in response to TCR engagement, we pretreated T
cells with 1 mM of the iNOS inhibitor 1400W (Alderton
et al., 2001), 30 mM of the nNOS inhibitor TRIM (Handy
et al., 1996), or 1 mM of L-NAME, which preferentially in-
hibits the activity of eNOS and nNOS at this concentra-
tion (Furfine et al., 1993). Whereas 1400W and TRIM
had no effect on NO release from J77 or primary T cells,
1 mM of L-NAME completely abolished it (Figure 2A).
This evidence for the involvement of eNOS in the rapid
onset of NO release upon TCR engagement was corrob-
orated in highly purified T lymphoblasts from eNOS
knockout mice, which produced substantially lower
amounts of NO than wild-type T cells (Figure 2B).
To ascertain whether eNOS was indeed the source of
NO in stimulated T lymphocytes, we studied the expres-
sion of eNOS and iNOS mRNA in highly purified wild-
type and eNOS-deficient mouse T lymphoblasts, highly
purified human T lymphoblasts, and J77 cells. The RT-
PCR of mRNA isolated from all these cell types except
for eNOS-deficient T lymphoblasts amplified an eNOS-
specific cDNA fragment (Figure 2C). In contrast, iNOS
mRNA was detected only in mouse T lymphoblasts
(Figure 2C). These results were confirmed at protein
level by immunoprecipitation analysis in nonstimulated
J77 cells and human T lymphoblasts; despite our efforts
to detect iNOS and nNOS, only eNOS was clearly de-
tected (Figure 2D).
Immunofluorescence experiments showed that eNOS
partially colocalized with a-tubulin around the micro-
tubule-organizing center (MTOC) of J77 cells and con-
centrated near the contact site with Raji cells in the
presence of SEE but not in its absence (Figure 2E).
In contrast, neither iNOS nor nNOS were observed in
nonstimulated T cells (Figure 2E and data not shown).
Similar results were obtained in T cell-APC conjugates
between human T lymphoblasts and SEE-pulsed Raji
cells (Figure 2F).
Ca2+ Release and PI3-K Activity Are Required for
Antigen-Specific Production of NO in T Cells
To investigate whether eNOS is activated in a Ca2+-de-
pendent manner by PI3-K in response to TCR engage-
ment, we first monitored Ca2+ release and NO produc-
tion in J77 cells loaded with the Ca2+ probe Fluo-4 AM
(Figure 3). NO and intracellular Ca2+ increased almost
concomitantly upon engagement of the TCR by CD3
Abs, but NO release was prevented by pretreatment
with the Ca2+ chelator BAPTA-AM in the absence of ex-
tracellular Ca2+ (Figures 3A, 3B, and 3E). Pretreatment of
cells with thapsigargin, which elevates intracellular Ca2+
through store depletion, did not increase the production
of NO from nonactivated T cells (Figures 3C and 3E),
whereas NO production was increased in the presence
of CD3 Abs (Figures 3D and 3E). This indicates that
Ca2+ flux by itself is insufficient for NO synthesis in
response to TCR engagement. Similar results were
obtained in antigen-specific CH7C17-HOM-2 and super-
antigen-specific J77-Raji cell conjugates (Figure 3E).
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755Figure 1. CD3 Antibodies, Superantigens, and Antigenic Peptides Stimulate the Production of NO in T Cells
(A) Electrochemical detection of NO gas production in J77 cells, highly purified T lymphoblasts, and PBTs after addition of CD3 Ab (5 mg/ml each)
for 10 min followed by GAM IgG crosslinking (10 mg/ml). In control experiments, cells were stimulated with a mouse isotype-matched IgG, CD45
Ab, or pretreated with NLA (500 mM). The bar graphs depict NO production after 40 min. Bar graphs show mean 6 SEM of four independent
experiments.
(B) Production of NO in J77-Raji and CH7C17-HOM-2 cell conjugates in presence of SEE (1 mg/ml) and HA307-319 peptide (200 mg/ml), respec-
tively. For controls, non-antigen-pulsed APC or Raji cells fixed in 1% paraformaldehyde and extensively washed before pulsing with SEE or NLA-
pretreated T cells were used. NO was detected after 40 min. Bar graphs show mean 6 SEM of four independent experiments.
(C) Subcellular production of NO in J77 cells (top) or CH7C17 cells (bottom) loaded with 1 mM DAF-FM diacetate and mixed for 30 min with SEE-
pulsed Raji cells or HA307-319-pulsed HOM-2 cells. NO production (green) was monitored by fluorescence microscopy. Fluorescence staining of
APC (blue) is superimposed on the DIC images. A representative T cell-APC conjugate is shown.
(D) Percentage of J77 cells with MTOC and NO polarization in cell conjugates with nonpulsed (2SEE) or SEE-pulsed (+SEE) Raji cells 6 NLA.
More than 500 cells for each condition were scored. At the bottom, the ratios of subcellular DAF-FM fluorescence (cell-cell contact/cytoplasm)
are indicated. Bar graphs show mean 6 SEM of three independent experiments.
(E) Mature (mDCs) or immature (iDCs) dendritic cells were incubated with SEE, SEA, and SEB (1 mg/ml total) for 20 min, and then mixed with
T lymphoblasts from the same donor at a 1:3 ratio. NO was detected after 40 min. For control incubations, non-antigen-pulsed DC were
used, or T lymphoblasts were preincubated with NLA. The arithmetic mean 6 SEM of four independent experiments is shown.
(F) T lymphoblasts were loaded with DAF-FM and mixed for 30 min with mature DC as in (E). T-lymphoblast-DC junctions were stained with CD3
Ab (red), and sites of NO production are shown by DAF-FM (green). A representative T cell-APC conjugate from three independent experiments is
shown.To investigate the possible role of PI3-K, we pretreated
J77 cells with wortmannin or LY294002, two structurally
unrelated PI3-K inhibitors. Both pretreatments substan-
tially inhibited the production of NO in cells activated by
CD3 Abs, while having little effect on Ca2+ release (Fig-
ures 4A and 4B and data not shown). Similar results
were obtained in antigen- and superantigen-specific
T cell-APC conjugates (Figure 4B). The importance ofPI3-K for the production of NO in T cells was confirmed
in J77 cells transiently transfected with p85wt or Dp85
(the wild-type regulatory subunit of PI3K and a domi-
nant-negative form lacking the SH2 binding domain, re-
spectively; Figure 4C). The production of NO was slightly
higher in J77 cells transfected with p85wt than in mock-
transfected cells, but was substantially decreased in
cells expressing Dp85 (Figure 4C).
Immunity
756Figure 2. J77 Cells and Primary T Lympho-
blasts Express eNOS
(A) Electrochemical detection of NO produc-
tion in J77 cells, T lymphoblasts, and PBTs
pretreated with specific NOS inhibitors. Cells
were pretreated with 1400W (1 mM), TRIM
(30 mM), or L-NAME (1 mM) and stimulated
with CD3 Ab followed by IgG crosslinking.
NO was detected after 40 min. Bar graphs
show mean 6 SEM of four independent
experiments.
(B) Electrochemical detection of NO produc-
tion in T lymphoblasts from wild-type (wt) or
eNOS-deficient (eNOS KO) mice after addi-
tion of CD3 Ab and GAR IgG crosslinking 6
NLA (500 mM). Bar graphs show mean 6
SEM of four independent experiments.
(C) Semiquantitative RT-PCR of eNOS and
iNOSin nonstimulated humanT lymphoblasts,
highly purified (h.p.) T lymphoblasts, highly
purified wild-type (wt), and eNOS-deficient
(KO) mouse T lymphoblasts and J77 cells.
HUVEC and iNOS-transfected-HEK-293 were
also included. Controls were human b-actin
andmouse GAPDH. Numbers in the lanes indi-
cate n-fold expression values of eNOS mRNA
in human T lymphoblasts relative to J77 cells.
(D) Immunoprecipitation of iNOS, eNOS, and
nNOS in nonstimulated T lymphoblasts and
J77 cells. Control immunoprecipitations were
from, respectively, iNOS-transfected HEK-
293, HUVEC, and rat brain cell extracts.
(E) Subcellular localization of NOS in J77-Raji
cell conjugates 6 SEE. Cells were stained for
a-tubulin (green) and eNOS or iNOS (red).
CMAC staining of Raji cells (blue) is superim-
posed over the corresponding DIC images.
(F) Subcellular localization of eNOS in T lym-
phoblasts. CMAC-labeled Raji cells (blue)
were pulsed with SEE and mixed for 30 min
with highly purified 10 day human T lympho-
blasts obtained from SEE-stimulated PBLs.
T cell-APC conjugates were then stained for
a-tubulin (green) and eNOS or iNOS (red).
Fluorescence and DIC superimposed images
are also shown. Note in the eNOS DIC picture
the spread of the Raji plasma membrane and
contacts with T cells.eNOS Colocalizes with the Golgi Apparatus
in Specific T Cell-APC Conjugates
To further investigate the role of eNOS in T cell-APC con-
jugates, we stably transfected J77 cells with a constructof the green fluorescent protein (GFP) linked to eNOS
(eNOS-GFP), and cells expressing moderate amounts
of eNOS-GFP were selected by fluorescence-activated
cell sorting (Figure 5A). These cells showed a 2-fold
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757higher production of NO in response to SEE than control
cells (Figure 5B).
To investigate the subcellular localization of eNOS
during the activation of living T cells, we labeled cells
with BODIPY Texas red ceramide, a fluorescent
probe specific for the Golgi network. We found that
Figure 3. Ca2+ Release Is Required for Antigen-Specific NO Produc-
tion in T Cells
(A–D) NO gas production and [Ca2+]i release were monitored for the
times indicated by electrochemical detection and flow cytometry,
respectively, in J77 cells that had been treated as follows: (A) CD3
Ab followed by IgG cross linking; (B) the Ca2+ chelator BAPTA-AM
(10 mM) in absence of extracellular Ca2+ before CD3 Ab plus IgG
crosslinking; (C) thapsigargin (1 mM); and (D) thapsigargin followed
by CD3 Ab plus IgG crosslinking.
(E) Accumulated NO release over 40 min from J77 cells activated by
CD3 Ab (white) or SEE-pulsed Raji cells (black), or from CH7C17 cells
activated by HA-pulsed HOM-2 cells (gray). For controls, CD3 Ab was
omitted (IgG) or non-antigen-pulsed Raji and HOM-2 cells were used
(2SEE and2HA). Where indicated, cells were preincubated with NLA
(500 mM) or BAPTA-AM (10 mM) or treated with thapsigargin (1 mM)
alone or together with antibody or APC stimulation. Bar graphs
show mean 6 SEM of four independent experiments.eNOS-GFP mainly colocalized with the Golgi even in
the absence of SEE (Figure 5C). In contrast, the expres-
sion of eNOS-GFP at the plasma membrane was almost
undetectable (Figure 5C). In the presence of SEE, the
eNOS-GFP-Golgi complex was reoriented toward the
junction with the APC (Figures 5C and 5D). This cotrans-
location of eNOS-GFP and Golgi was observed in 80%
of SEE-specific conjugates between eNOS-GFP-trans-
fected J77 and Raji cells (Figure 5E); separate trans-
location of either eNOS or the Golgi apparatus was not
observed (Figure 5E).
eNOS Activation in Antigen-Specific
T Cell-APC Conjugates
To investigate whether eNOS is activated at the immu-
nological synapse, eNOS-GFP-transfected J77 cells
were loaded with the NO probe DAR-4M AM and the lo-
calization of eNOS and the release of NO in T cell-APC
conjugates were simultaneously studied by time-lapse
confocal fluorescence microscopy (Figure 6). In the ab-
sence of SEE, we observed neither the translocation of
eNOS-GFP nor increased production of NO (Figure 6A).
In contrast, in the presence of SEE, eNOS-GFP began to
translocate toward the APC as soon as the initial contact
was established (Figure 6B). Translocation to the con-
tact zone was complete after 8 min, and the enzyme re-
mained there for at least 30 min. Production of NO also
increased progressively from the time of initial cell-cell
contact, reaching maximal levels after 20 min, and was
also concentrated at the inner face of the contact site
with the APC (Figure 6B). The production of NO was
similarly localized in T cell-APC conjugates in which
J77 cells express undetectable levels of eNOS-GFP, al-
though NO production was higher in J77 cells express-
ing eNOS-GFP (Figure 6C).
We quantified the relationship between the transloca-
tion of eNOS and its activation. In the absence of SEE,
neither eNOS localization nor NO production showed
any correlation with time (Figure 6D); in the presence
of SEE, the activity of eNOS progressively increased
as the proximity of the enzyme to the T cell-APC contact
site progressively decreased (Figure 6E).
To examine the relationship between the activation of
eNOS and PI3-K-Akt, we analyzed the phosphorylation
of eNOS-GFP and Akt at serines 1179 and 473, respec-
tively. Phosphorylation of both proteins reached a maxi-
mum 15 min after the initial formation of T cell-APC con-
tacts (Figure 6F). These results strongly suggest that Akt
regulates the synthesis of NO near the immunological
synapse via the specific phosphorylation of eNOS.
eNOS Regulates CD3 Distribution and TCR Signal
Strength
To determine whether the localized production of NO at
the T cell-APC contact site plays a role in the organiza-
tion of the immune synapse, we analyzed the clustering
of CD3 on J77-Raji cell conjugates. Whereas CD3 on
control (GFP-transfected) J77 cells was concentrated
in a small central area of the contact zone with Raji cells,
on eNOS-GFP-transfected cells the area occupied
by CD3 was greatly increased, and its coalescence at
the cSMAC of T cell-APC synapses was impaired (Fig-
ure 7A). This effect was prevented by pretreatment of
cells with NLA (Figure 7A), suggesting that the dispersed
Immunity
758Figure 4. PI3-K Activity Is Required for Antigen-Specific Production of NO in T Cells
(A) Electrochemical detection of NO gas production and [Ca2+]i release in J77 cells preincubated with the PI3-K inhibitor LY294002 (10 mM) and
activated by CD3 Ab plus IgG crosslinking.
(B) Accumulated NO release over 40 min from J77 cells activated by CD3 Ab plus IgG crosslinking (white) or SEE-pulsed Raji cells (black), or from
CH7C17 cells activated by HA-pulsed HOM-2 cells (gray). Where indicated, cells were preincubated with NLA (500 mM), wortmannin (100 nM), or
LY294002 with or without antibody or APC stimulation. Bar graphs show mean 6 SEM of four independent experiments.
(C) Accumulated NO release by J77 cells transfected with pCDNA3, wild-type p85, or Dp85, and activated by CD3 Ab plus IgG crosslinking. X63
mAb was used as a negative control, and where indicated NO synthesis was blocked with NLA. Immunoblots show the expression of p85 and
a-tubulin. Bar graphs show mean 6 SEM of three independent experiments.CD3 distribution results from the overactivation of
eNOS-GFP near the immune synapse.
Phosphorylation on tyrosine of the TCR CD3z chain
and of its associated tyrosine kinase ZAP-70 was en-
hanced in eNOS-GFP-transfected J77 cells (Figures 7B
and 7C), indicating that the dispersion of CD3 at the
immune synapse of eNOS-transfected cells activates
signaling downstream the TCR. Extracellular signal-reg-
ulated kinases (ERK) have been reported to function as
integrators of TCR signal strength downstream CD3z
and ZAP-70 (Schade and Levine, 2004). Overexpression
of eNOS markedly increased ERK phosphorylation upon
APC binding, peaking within 15–40 min from the initial
formation of cell conjugates (Figure 7D). This increased
ERK phosphorylation was reduced by pretreatment of
cells with NLA (Figure 7D).
These results were corroborated in T lymphoblasts
from eNOS-deficient mice. In these cells, the activation
of ERK in response to CD3 engagement was less sus-
tained than in wild-type cells, and the pretreatment
with the NO donor DETA-NO restored it substantially
(Figure 7E). We also asked whether the NO-dependent
activation of ERK was mediated by cGMP. Although
8BrcGMP slightly increases ERK activation in SEE-stim-
ulated J77 cells, neither ODQ nor KT5823—two potent
inhibitors of the guanylate cyclase and the G kinase
(GK), respectively—exerted a substantial effect on
ERK activity (Figure 7F). This is despite the fact thatODQ and NLA each blocked SEE-dependent cGMP syn-
thesis in these cells (Figure 7G). These results indicate
that eNOS regulates T cell receptor signaling to antigen
via a cGMP-independent mechanism.
To address the effect of eNOS on cytokine synthesis,
we also assessed the production of IL-2 and IFN-g in
response to SEE in eNOS-GFP-transfected J77 cells
(Figures 7H and 7I). Whereas overexpression of eNOS
reduced the secretion and mRNA synthesis of IL-2 (Fig-
ures 7H and 7I), the expression of IFN-g increased in
response to SEE (Figure 7I). Pretreatment with NLA re-
stored the synthesis of IL-2 and IFN-g mRNA to levels
near those observed in SEE-stimulated controls
(Figure 7I). These findings indicate that eNOS-derived
NO selectively regulates cytokine production in T cells,
increasing IFN-g synthesis, but reducing the production
of IL-2.
Discussion
The response of T cells to antigens depends of the sig-
naling network connected to the TCR. Although NO has
been implicated in the regulation of cytokine expression
and T cell proliferation, the underlying mechanisms
through which it exerts these activities are poorly under-
stood (Bogdan, 2001). Moreover, although NO donors
and nonlymphocyte cellular sources of NO have pro-
vided valuable insights into the effects of NO on T cell
eNOS Regulates TCR Signaling
759Figure 5. eNOS Colocalizes with Golgi and Translocates to the Contact Site in Superantigen-Specific T Cell-APC Conjugates
(A) Flow cytometry analysis of GFP fluorescence in eNOS-GFP-transfected and control J77 cells.
(B) NO release over 40 min from GFP-transfected (J77-GFP) or eNOS-transfected (J77-eNOS-GFP) J77-Raji cell conjugates 6 SEE. Where
indicated, cells were preincubated with 500 mM NLA. Bar graphs show mean 6 SEM of four independent experiments.
(C) J77 cells expressing eNOS-GFP (green) were loaded with the Golgi-specific fluorescent probe BODIPY-TR ceramide (red) and mixed for 30
min with nonpulsed (2SEE) or SEE-pulsed (+SEE) Raji cells. Images show real-time confocal microscopy of live cells; merged fluorescence and
DIC images are shown to the right; scale bar equals 8 mm.
(D) Cotranslocation dynamics of eNOS-GFP and Golgi in superantigen-specific T cell-APC conjugates. Each frame shows DIC pictures super-
imposed on the fluorescence of eNOS-GFP (green), Golgi (red) and Raji (blue) cells. Time from initial cell contact is indicated in minutes at the
lower left corner of each image.
(E) Translocation percentages of eNOS-GFP and the Golgi, singly or together, to the contact site of eNOS-GFP-transfected J77 and Raji cells6
SEE. Bar graphs show mean 6 SEM of four independent experiments.biology, the expression and function of NOS in T cells
during antigen-specific interactions with APC have re-
ceived less attention.
In this study, we have investigated the production of
NO by T cells as a response to the engagement of the
TCR. For this, we used electrochemical detection and
real-time fluorescence confocal microscopy with fluo-
rescent probes to detect NO in T cells conjugated to
APC presenting superantigens or antigenic peptides.
These approaches revealed that antigen-induced NOproduction in T cells is an early event, beginning a few
minutes after the release of Ca2+, and is sustained for
at least 60 min. Our results are consistent with previous
work indicating that human T cells produce NO in re-
sponse to either superantigens or CD3 and CD28 costi-
mulation (Sriskandan et al., 1996; Nagy et al., 2003).
However, these earlier studies focused on NO produc-
tion at least 3 hr after stimulation, long after the major
part of signaling elicited by antigen binding to the
TCR, which takes place within minutes. This rapid
Immunity
760Figure 6. Dynamics of eNOS Translocation and NO Production in Specific T Cell-APC Conjugates
(A and B) J77 cells transiently transfected with eNOS-GFP were loaded with the NO probe DAR-4M AM (0.5 mM) and then mixed with control (A) or
SEE-pulsed Raji cells (B). Cell images were recorded at 2 min intervals by real-time confocal fluorescence microscopy. Selected images show the
translocation of eNOS-GFP (green) and the release of NO (red). The asterisks mark Raji cells in conjugates that were stained with CMAC to
facilitate cell tracking. Time in minutes is indicated at the bottom left of DIC images; scale bar equals 4 mm. A representative experiment of three
is shown.
(C) NO production at 30 min in T cell-SEE-Raji conjugates with J77 cells expressing eNOS-GFP.
(D and E) NO production (closed circle) and the distance (mm) between eNOS-GFP and the Raji contact site (closed triangle) in J77-eNOS-GFP
exposed to control and SEE-loaded Raji cells, respectively. NO production is presented as mean DAR-4M AM fluorescence (in arbitrary units:
AR). Downward arrows indicate the time when intercellular contacts were first observed.
(F) Time course of Akt and eNOS phosphorylation in conjugates of eNOS-transfected J77 and SEE-pulsed Raji cells. Both cell types were serum
starved for 4 hr before mixing. Phosphorylated and total Akt and eNOS-GFP proteins were detected by immunoblot.Ca2+-dependent production of NO is consistent with the
involvement of constitutively expressed NOS isoen-
zymes. To date, it has been questionable whether
T lymphocytes express any of the NOS isoenzymes.
Whereas iNOS expression has been reported in Jurkat
cells (Mannick et al., 1999) and mouse T lymphoblasts
(Vig et al., 2004), its expression in primary human T cells
has been suggested (Vig et al., 2004). Evidence has re-
cently relied on its detection by immunohistochemistry
of graft-infiltrating human T lymphocytes in murineimmunodeficient hosts (Koh et al., 2004). In contrast, an-
other report has shown that neither human T cell lines
nor PBTs express iNOS at mRNA level, unless they
were infected with the human T cell leukemia virus
type I (Mori et al., 1999), suggesting that signals regulat-
ing the expression of iNOS in T cells may be species
specific or activated in virus-infected leukemic cells.
Our experiments demonstrate that eNOS is expressed
in nonstimulated human and mouse T cells and is there-
fore the most likely endogenous source of NO in specific
eNOS Regulates TCR Signaling
761T cell-APC conjugates. This finding confirms previous
work showing constitutive expression of eNOS in Jurkat
and primary T cells (Reiling et al., 1996), which is en-
hanced by mitogenic agents (Sciorati et al., 1997; Nagy
et al., 2003). We have also found that the activity of ex-
tant eNOS is increased in T cells within minutes of their
activation by coordinate regulation via [Ca2+]i release
and Akt-mediated phosphorylation.
Like other free radicals, NO has a short reactive half-
life. The focal production of NO in T lymphocytes is
therefore likely to favor activity at subcellular domains
close to the APC contact site, where signaling molecules
concentrate. In nonlymphocyte cell lineages, eNOS lo-
calizes either at the Golgi apparatus, where it is highly
responsive to Akt (Fulton et al., 2004), or at the plasma
membrane bound to caveolae. Remarkably, T lympho-
cytes and T cell lines have no caveolae (Fra et al.,
1994). Our imaging of the eNOS-GFP fusion protein in
T cell-APC conjugates confirms this, showing that
eNOS was almost undetectable at the plasma mem-
brane of T cells, irrespective of the presence of antigen.
These experiments showed that eNOS-GFP localizes to
the Golgi apparatus and translocates with it to the APC
contact site during T cell activation, where it is fully ac-
tivated. The complex mechanisms that regulate the ac-
tivation of eNOS by its subcellular localization are poorly
understood, but our data strongly suggest that essential
signals must be generated at the immune synapse to ac-
tivate eNOS. During T cell activation, PI3-K synthesizes
PIP3 for hours to recruit Akt to the immune synapse
(Costello et al., 2002; Harriague and Bismuth, 2002);
therefore, the translocation of the Golgi complex to the
immune synapse may facilitate the exchange of Akt be-
tween the plasma membrane and the Golgi for efficient
phosphorylation of eNOS. Indeed, such a mechanism
has been previously reported in the response of arterial
endothelial cells to insulin (Sasaki et al., 2003).
Our results show that activation of eNOS at the APC
contact site prevents the aggregation of CD3 at the
cSMAC. Although the precise role of the cSMAC is
only now beginning to be understood (Lin et al., 2005),
its importance is well accepted in regulating the sus-
tained signaling required for cytokine production and
cell proliferation as an adaptive controller to protect
cells from overstimulation (Huppa et al., 2003; Lee
et al., 2003). The strength of antigen binding to the
TCR, the clustering of receptors, and the activation of
transduction cascades are among the many factors
that affect the triggering and cessation of TCR signaling.
A computational model that takes these factors into ac-
count predicts that strong signaling could still take place
in the absence of CD3 coalescence at the cSMAC (Lee
et al., 2003). This fits well with our findings that cells
overexpressing eNOS did not fully concentrate CD3 at
the cSMAC in response to SEE, but enhanced early
CD3z and ZAP-70 tyrosine phosphorylation, ERK activa-
tion, and IFN-g synthesis. Despite the increased activa-
tion of early TCR signaling, our results also indicate that
eNOS-synthesized NO exerts an inhibitory effect on IL-2
production. This inhibitory effect is in agreement with
previous reports that showed that NO donors reduce
the secretion of IL-2 in human T cells activated with
CD3 plus CD28 Abs (Fiorucci et al., 2004). Suppressive
effects of cGMP on IL-2 release and activating effectson ERK have been reported to occur via GK (Fischer
et al., 2001). We found that eNOS-synthesized NO acti-
vates ERK through a cGMP-independent mechanism.
In this regard, NO has been also reported to activate
ERK and suppress T cell proliferation in Jurkat cells by
a cGMP-independent mechanism (Fischer et al., 2001),
suggesting that the effect of eNOS on IL-2 could occur
by cGMP-dependent and -independent mechanisms.
A differential pattern of IL-2 and IFN-g production and
a marked synthesis of NO have also been described
in mice pretreated and then restimulated with Staphy-
lococcus enterotoxin superantigen B (SEB) (Florquin
et al., 1995). Thus, a possible role can be postulated
for eNOS in regulating the differential cytokine expres-
sion by T cells during superantigen-triggered septic
shock: selective impairment of IL-2 production in mem-
ory T cells activated by strong binding antigens might
protect them from inappropriate expansion, maintaining
their capacity to produce IFN-g.
How NO synthesized by eNOS could prevent the coa-
lescence of CD3 at the cSMAC while increasing early
TCR signaling presents an intriguing question. A possi-
bility is that eNOS directly activates the Ras-ERK path-
way; and recent work on H- and N-Ras in Jurkat cells
is interesting in this regard. H- and N-Ras are localized
both in the plasma membrane and the Golgi complex,
but are activated almost exclusively in the Golgi appara-
tus by the redistribution of the GTP-exchanging factor
RasGRP1 from the cytosol (Bivona et al., 2003; Perez
de Castro et al., 2004). A more recent study proposed
a deacylation-reacylation cycle of palmitoylation as re-
sponsible for the rapid exchange of H- and N-Ras be-
tween the plasma membrane and the Golgi apparatus
(Rocks et al., 2005). In the same study, experiments
with the 20 N-terminal amino acids of eNOS suggested
that the subcellular localization of eNOS also depends
on deacylation-acylation cycles, with inefficient palmi-
toylation reducing localization at the plasma membrane.
This compartmentalization raises interesting sugges-
tions about the mechanism connecting eNOS with
ERK and about the organization of CD3 at the cSMAC.
Low concentrations of donor-derived NO activate ERK
in Jurkat cells via S-nitrosylation of Cys118 on H-Ras
and the consequent activation by GTP-GDP exchange
(Lander et al., 1996, 1997). On the other hand, ERK has
been involved in the regulation of proximal TCR signal
transduction events through a positive-feedback activa-
tion pathway characteristic of strong binding antigens
(Stefanova et al., 2003). Whether the dispersion of CD3
at the cSMAC is the consequence of a positive feedback
of ERK through a mechanism of S-nitrosylation on Ras
at the Golgi complex remains to be investigated.
In conclusion, we have shown that eNOS is rapidly ac-
tivated at the Golgi complex during its translocation to
the immunological synapse. The observation that early
TCR-proximal signaling and IFN-g synthesis increase
in cells overexpressing eNOS but that IL-2 synthesis de-
creases indicates that the localized production of NO at
the Golgi apparatus selectively potentiates TCR signal
strength to antigen. This provides new insights into the
role of eNOS in the early signaling events that determine
the outcome of the T cell-APC interaction in the initial
phase of adaptive immune responses, when NO from
iNOS-expressing inflammatory cells is still absent.
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Antibodies, Cells, and Reagents
Human CD45, CD3 T3b, and X63 mAbs have been previously de-
scribed (Serrador et al., 2004). Other antibodies were sourced as fol-
lows: anti-human CD16, anti-mouse CD3, NK1.1, and control IgG2b
from Immunotools (Friesoythe, Germany); anti-mouse CD3 KT3 from
Serotec (Oxford, UK); anti-CD3z 488 pAb from Dr. B. Alarco´n (CBM,
Madrid, Spain); anti-nNOS (610308), -iNOS (610328 and 610332),
and -eNOS (610296) from B.D.-Transduction Laboratories (Franklin
Lakes, NJ); anti-nNOS (N2280) and -a-tubulin from Sigma (St. Louis,
MO); anti-p85 and -phosphotyrosine 4G10 from Upstate Biotechnol-
ogy (Lake Placid, NY); anti-Akt, -phospho-Akt (Ser 473), -phospho-
eNOS (Ser1177), -ZAP-70, -phospho-ZAP-70 (Tyr493), -ERK1/2,
and -phospho-ERK1/2 pAbs from Cell Signaling (Beverly, MA); and
goat anti-mouse (GAM) and anti-rat (GAR) IgG from Calbiochem
(San Diego, CA).
Human peripheral blood lymphocytes, mouse splenocytes, and T
lymphoblasts were obtained as described (Mazzoni et al., 2002;
Schade and Levine, 2004). Highly purified human and mouse T lym-
phocytes and lymphoblasts were obtained by negative selection on
human and mouse T cell enrichment columns (R&D Systems, Minne-
apolis, MN). Cells eluted from the columns were labeled for CD16 or
NK1.1, and residual positive cells for these markers were depleted
by magnetic rabbit anti-mouse-coated dynabeads (Invitrogen,
Carlsbad, CA). The purity of the obtained T cells was analyzed by
flow cytometry, and the phenotype of PBTs and T lymphoblasts
was always 90%–95% and R99% CD3+, respectively. The Jurkat
T cell clone J77 and the Raji and HOM-2 lymphoblastoid B cell lines
were each grown in RPMI 1640 (GIBCO-BRL, Gaithesburg, MD) sup-
plemented with 10% FBS. CH7C17 Jurkat cells transfected with
a TCR specific for the influenza hemagluttinin (HA) peptide HA
307-319, PKYVKQNTLKLAT (Sigma) (Hewitt et al., 1992) were grown
in the presence of hygromycin (400 mg/ml) and puromycin (4 mg/ml).
Human monocyte-derived dendritic cells (DCs) were obtained simi-
larly as described (Harriague and Bismuth, 2002). At day 6, DC mat-
uration was induced with 10 ng/ml LPS (Sigma). iNOS-transfected
HEK-293 cells were from Dr. J. Mateo (CNIC, Madrid, Spain).
Staphylococcus enterotoxins-A, -B, and -E (SEA, SEB, and SEE)
were from Toxin Technology (Sarasota, FL). The blue fluorescent
cell tracker chloromethyl derivative aminocoumarin (CMAC), Fluo-
4 AM, and BODIPY Texas red ceramide were obtained from
Molecular Probes (Eugene, OR). Diaminofluorescein-FM diacetate
(DAF-FM DA), diaminorhodamine-4AM (DAR-4M AM), LY294002,wortmannin, and KT5823 were from CalbioChem; Poly-L-Lysine,
NLA, L-NAME, thapsigargin, BAPTA-AM, 8BrcGMP, and ODQ
were from Sigma; and 1400W, DETA-NO, and 1-(2-trifluoromethyl-
phenyl)imidazole (TRIM) were from Alexis (Carlsbad, CA).
Animals
Wild-type C57BL/6 and eNOS null mice (C57BL/6, 129)—a kind gift
of Dr. C. Zaragoza (CNIC, Madrid, Spain)—were housed in our ani-
mal facility in isolated rooms. All procedures involving animals and
their care were approved by the CNIC Ethics Committee.
T Cell Activation, NO Production, and cGMP Measurement
J77 (20 3 106), T lymphoblasts (20 3 106), or PBTs (25 3 106) were
resuspended in 1 ml Hank’s Balanced Salt Solution (HBSS). After ob-
taining a steady baseline NO reading, cells were activated under
continuous rotation as follows. For stimulation by TCR crosslinking,
CD3 T3b (5 mg/ml) was added to cells, and after 10 min, IgG (10 mg/
ml) was added for 50 min. For superantigen-specific stimulation, Raji
cells (53 106) were incubated with SEE (1 mg/ml) for 15 min, and then
mixed with J77 cells at 1:3 ratio. For antigen-specific stimulation,
HOM-2 cells (5 3 106/ml) were incubated at 37ºC for 3 hr with 200
mg/ml HA 307-319 peptide, and then mixed with CH7C17 cells at a
ratio of 1:3. For conjugates between primary T cells and APC, DCs
(53 106) were loaded with a mix of SEE, SEA, and SEB (1 mg/ml total)
for 20 min and then mixed with T lymphoblasts from the same
donor at 1:3 ratio.
NO production was monitored for 60 min with an ISO-NOP NO
electrode (World Precision Instruments, Stevenage, UK), which
was calibrated against known concentrations of NaNO2 under re-
ducing conditions (KI/H2SO4) at 37ºC. cGMP was measured with




ELISA and immunofluorescence were as described (Serrador et al.,
2004). For double immunofluorescence staining of NOS and a-tubu-
lin, cells were permeabilized for 30 s in 0.2% Triton X-100 and then
incubated with iNOS (610328), nNOS (610308), or eNOS (610296)
mAbs (with TRITC-conjugated GAM as secondary antibody) and
a FITC-labeled a-tubulin mAb. Cells were viewed under a Leica
TCS-SP confocal microscope (Heidelberg, Germany). Immunopre-
cipitations and immunoblotting were as described (Serrador et al.,
2004). In brief, cell lysates from T lymphoblasts (2.53 107) or J77 cellsFigure 7. NO Synthesis by eNOS Prevents the Coalescence of CD3 at the cSMAC and Increases Antigen-Induced Early TCR Signaling through
a cGMP-Independent Mechanism
(A) Control GFP and eNOS-GFP J77 cells without pretreatment or pretreated with 300 mM NLA were mixed for 30 min with SEE-pulsed Raji cells in
0.1 mM L-Arg RPMI medium. Cells were fixed and stained with CD3 Ab and analyzed by confocal microscopy. Asterisks in DIC pictures indicate
Raji cells. The chart shows quantitative image analysis of X-Z and X-Y plane projection of immune synapses for each condition, with all CD3-
occupied areas calculated by computer-assisted image analysis; the data are means 6 SEM of three independent experiments.
(B) Time course of CD3z phosphorylation in eNOS-GFP- and GFP-transfected J77 cells mixed with SEE-pulsed Raji cells for the times indicated
and immunoprecipitated with CD3z pAb. Phosphorylated and total CD3z were detected by immunoblot with phosphotyrosine 4G10 mAb and
CD3z pAb, respectively.
(C) Phosphorylation of ZAP-70 in eNOS-GFP- and GFP-transfected J77 cells mixed with SEE-pulsed Raji cells for the times indicated. Phosphor-
ylated and total ZAP-70 were detected by immunoblot.
(D) Time course of ERK activation in GFP and eNOS-GFP J77 cells mixed with SEE-loaded Raji cells in 0.1 mM L-Arg RPMI medium for the times
indicated. Where indicated, cells were pretreated with NLA. Phosphorylated and total ERK were detected by immunoblot.
(E) Time course of ERK activation in eNOS-deficient mouse T lymphoblasts. Wild-type (wt) and eNOS-deficient (KO) T lymphoblasts were stim-
ulated with CD3 Ab KT3 and GAR IgG crosslinking for the times indicated. Where indicated, cells were pretreated with 100 mM DETA-NO, which
yielded a steady-state concentration of 99 6 3 nM NO (n = 4) as measured by an NO electrode.
(F) eNOS-synthesized NO activates ERK by a cGMP-independent mechanism. eNOS-GFP-transfected J77 cells were mixed with unpulsed or
SEE-pulsed Raji cells at a 1:3 ratio for 15 min either after pretreatment for 1 hr with 3 mM ODQ or 1 mM KT5823 or in the presence of 100 mM
8BrcGMP or KT5823 plus 8BrGMP (KT-8Br). The results of densitometric analysis are indicated. One representative experiment out of three
is shown.
(G) Cyclic GMP production at 60 min in GFP- or eNOS-GFP-transfected J77-Raji cell conjugates 6 SEE in the presence of ODQ or NLA as
indicated. Bar graphs show mean 6 SEM of three independent experiments.
(H) IL-2 secretion at 24 hr from J77, GFP, and eNOS-GFP-transfected J77 cells mixed with nonpulsed (2SEE) or SEE-pulsed (+SEE) Raji cells.
Results show the arithmetic mean 6 SEM of three independent experiments.
(I) Real-time RT-PCR of IL-2 and IFN-g gene expression at 90 min in SEE-pulsed Raji and eNOS-GFP-transfected J77 cells mixed as in (D).
Expression levels were normalized to GAPDH and are presented as the SEE-dependent fold increase of eNOS-GFP-transfected J77 cells in pres-
ence or absence of NLA, relative to SEE-dependent expression in control GFP-transfected J77 cells (value: 1). Bar graphs show mean6 SEM of
three independent experiments.
Immunity
764(1.5 3 107) were incubated overnight at 4ºC with 3.75 mg/ml specific
NOS antibodies (anti-nNOS N2280; -iNOS 610328; or -eNOS 610296)
and subsequently incubated with protein G-Sepharose beads for
1 hr. After five washes in lysis buffer, immunocomplexes bound to
protein G-Sepharose beads were collected by centrifugation.
Proteins were eluted by boiling in Laemmli sample buffer containing
10% 2-mercaptoethanol and processed for immunoblotting. To
detect nNOS, iNOS, and eNOS, membranes were incubated with
antibodies 610308, 610332, and 610296, respectively.
Cell Transfection Studies and Cell Sorting
Plasmid eNOS-GFP pcDNA3 was generously provided by Dr. W.
Sessa (Yale University, New Haven, CT). J77 cells (15 3 106) were
transiently transfected with 25 mg of plasmid encoding GFP,
eNOS-GFP, wild-type p85 subunit of PI3-kinase (p85wt), or a domi-
nant-negative mutated form (D85) at 250V and 1400 mF with the
Pulser X-cell Electroporation System (BioRad, Hercules, CA). Empty
pcDNA3 vector was used as a control for p85 transfections. To gen-
erate J77 cells stably transfected with eNOS-GFP and GFP, cells
were transferred 48 hr after transfection to RPMI medium supple-
mented with geneticin (1 mg/ml). After 3 weeks, viable cells express-
ing eNOS-GFP or GFP were sterile sorted with an EPICS Altra cell
sorter (Beckman-Coulter).
Flow Cytometry Analysis of Ca2+ Release
The kinetics of intracellular Ca2+ mobilization were evaluated in
T cells loaded with Fluo-4 AM. A detailed protocol can be found in
the Supplemental Data available with this article online.




Total RNA was extracted with the RNeasy kit (Qiagen, Hildesheim,
Germany), and cDNAs were generated from 2 mg RNA in the presence
of random hexamer primers with the SuperScriptRNaseH-Reverse
Transcriptase kit (Invitrogen). Gene expression levels were deter-
mined by real-time PCR by means of LightCycler FastStart DNA Mas-
ter SYBR Green I (Roche) containing 2 ml cDNA and 500 nM primer.
Details of the primers used and data analysis can be found in the
Supplemental Data.
Supplemental Data
Supplemental Experimental Procedures can be found with this
article online at http://www.immunity.com/cgi/content/full/24/6/
753/DC1/.
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